The move from the Small Cap segment is a result of Nasdaq’s annual review of the average market values within the Nordic market segments. The Mid Cap segment includes companies with a share value between
© Modular Finance, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.202 SEK | -1.70% | -5.39% | -97.98% |
02/05 | Xbrane Biopharma AB Appoints Kristoffer Bissessar Was Elected as New Director | CI |
22/04 | Transcript : Xbrane Biopharma AB - Special Call |
The move from the Small Cap segment is a result of Nasdaq’s annual review of the average market values within the Nordic market segments. The Mid Cap segment includes companies with a share value between
© Modular Finance, source
1st Jan change | Capi. | |
---|---|---|
-97.98% | 28.6M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |